Annals of the Rheumatic Diseases: 79 (8)

Editorials

Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs (11 June, 2020) Free
John D Isaacs, Gerd R Burmester
Kawasaki disease or Kawasaki syndrome? (22 June, 2020) Free
Angelo Ravelli, Alberto Martini

Heroes and pillars of rheumatology

Eric Bywaters a life story: 1 June 1910 to 2 April 2003 (26 May, 2020)
David Isenberg

Epidemiology

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort (11 June, 2020) Free
Marie Pouletty, Charlotte Borocco, Naim Ouldali, Marion Caseris, Romain Basmaci, Noémie Lachaume, Philippe Bensaid, Samia Pichard, Hanane Kouider, Guillaume Morelle, Irina Craiu, Corinne Pondarre, Anna Deho, Arielle Maroni, Mehdi Oualha, Zahir Amoura, Julien Haroche, Juliette Chommeloux, Fanny Bajolle, Constance Beyler, Stéphane Bonacorsi, Guislaine Carcelain, Isabelle Koné-Paut, Brigitte Bader-Meunier, Albert Faye, Ulrich Meinzer, Caroline Galeotti, Isabelle Melki
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China (22 May, 2020)
Cong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Jixin Zhong, Lingli Dong
Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the global burden of disease study 2017 (15 May, 2020)
Ziyi Jin, Dandan Wang, Huayong Zhang, Jun Liang, Xuebing Feng, Jinkou Zhao, Lingyun Sun

Rheumatoid arthritis

Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study (13 May, 2020)
Paul Emery, Gerd R Burmester, Esperanza Naredo, Luigi Sinigaglia, Ivan Lagunes, Franziska Koenigsbauer, Philip G Conaghan

Psoriatic arthritis

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis (18 May, 2020)
Emma Dures, Julie Taylor, Sasha Shepperd, Sandeep Mukherjee, Joanna Robson, Ivo Vlaev, Nicola Walsh, Laura C Coates
Novel and reliable DACTylitis glObal Sonographic (DACTOS) score in psoriatic arthritis (19 May, 2020)
Alen Zabotti, Garifallia Sakellariou, Ilaria Tinazzi, Luca Idolazzi, Alberto Batticciotto, Marco Canzoni, Greta Carrara, Orazio De Lucia, Fabiana Figus, Nicolò Girolimetto, Pierluigi Macchioni, Rebecca McConnell, Niccolò Possemato, Annamaria Iagnocco
Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression (13 May, 2020)
Abdulla Watad, Hannah Rowe, Tobias Russell, Qiao Zhou, Lisa K Anderson, Almas Khan, Robert Dunsmuir, Peter Loughenbury, Vishal Borse, Abhay Rao, Peter A Millner, Nicola Luigi Bragazzi, Howard Amital, Richard Cuhtbert, Miriam Wittmann, Kassem Sharif, Tony Kenna, Matthew A Brown, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

Spondyloarthritis

Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register (10 June, 2020)
Rosemary J Hollick, Kevin Stelfox, Linda E Dean, Joanna Shim, Karen Walker-Bone, Gary J Macfarlane
MRI of sacroiliac joints for the diagnosis of axial SpA: prevalence of inflammatory and structural lesions in nulliparous, early postpartum and late postpartum women (10 June, 2020)
Adel Hoballah, Cédric Lukas, Christophe Leplat, Patrice Taourel, Jean-Baptiste Pialat, Nicolas Sans, Sonia Ramos-Pascual, Catherine Cyteval

Systemic lupus erythematosus

Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis (24 May, 2020)
Chi Chiu Mok, Ling Yin Ho, Shirley King Yee Ying, Man Chi Leung, Chi Hung To, Woon Leung Ng
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis (5 June, 2020)
Gabriella Moroni, Mariele Gatto, Francesco Tamborini, Silvana Quaglini, Francesca Radice, Francesca Saccon, Giulia Frontini, Federico Alberici, Lucia Sacchi, Valentina Binda, Barbara Trezzi, Augusto Vaglio, Piergiorgio Messa, Renato Alberto Sinico, Andrea Doria

Systemic sclerosis

Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study (14 May, 2020)
Sandra van Bijnen, Jeska de Vries-Bouwstra, Cornelia H van den Ende, Maaike Boonstra, Lucie Kroft, Bram Geurts, Miranda Snoeren, Anne Schouffoer, Julia Spierings, Jacob M van Laar, Tom WJ Huizinga, Alexandre Voskuyl, Erik Marijt, Walter van der Velden, Frank HJ van den Hoogen, Madelon C Vonk

Adult Still’s disease

Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial (13 May, 2020)
Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Joerg Christoph Henes, Joern Kekow, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Eva Seipelt, Christof Specker, Eugen Feist

Behcet’s disease

Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet’s phenotype: a multicentre study (7 May, 2020)
Filippo Fagni, Alessandra Bettiol, Rosaria Talarico, Giuseppe Lopalco, Elena Silvestri, Maria Letizia Urban, Paul A J Russo, Gerardo Di Scala, Giacomo Emmi, Domenico Prisco

Osteoarthritis

Does cartilage loss cause pain in osteoarthritis and if so, how much? (7 May, 2020) Free
Kathryn Bacon, Michael P LaValley, S Reza Jafarzadeh, David Felson
TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination (14 May, 2020)
Gangliang Wang, Shuai Chen, Ziang Xie, Shuying Shen, Wenbin Xu, Wenxiang Chen, Xiang Li, Yizheng Wu, Liangping Li, Bin Liu, Xianjun Ding, An Qin, Shunwu Fan

Letters

Patient discussions of glucocorticoid-related side effects within an online health community forum (25 March, 2020)
Arani Vivekanantham, Maksim Belousov, Lamiece Hassan, Goran Nenadic, William G Dixon
Gender disparity in authorship of guidelines and recommendations in rheumatology (26 February, 2020)
Giovanni Adami, Camilla Benini, Elisabetta Vantaggiato, Denise Rotta, Ombretta Viapiana, Davide Gatti, Maurizio Rossini, Annamaria Iagnocco
Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database (25 March, 2020)
Michael Hughes, Calvin Heal, Elise Siegert, Eric Hachulla, Paolo Airó, Antonella Riccardi, Oliver Distler, Marco Matucci-Cerinic
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis (25 March, 2020)
Saki Kuwabara, Shun Tanimura, Shogo Matsumoto, Hiroyuki Nakamura, Tetsuya Horita
Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study (25 March, 2020)
Augustin Latourte, Hang-Korng Ea, Aline Frazier, Anne Blanchard, Frédéric Lioté, Hubert Marotte, Thomas Bardin, Pascal Richette

Electronic pages

Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al
(2 May, 2019) Free
Nathalie Costedoat-Chalumeau, David Isenberg, Michelle Petri
Hydroxychloroquine dosing in systemic lupus erythematosus: response to ‘Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al’ by Costedoat-Chalumeau et al
(14 June, 2019) Free
Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas
Decision-making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat? (15 May, 2019) Free
Chuiwen Deng, Xiaohui Qu, Shaoyun Cheng, Xiaofeng Zeng, Yongzhe Li, Yunyun Fei
Response to ‘Decision making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?’ by Deng et al
(15 May, 2019) Free
Luis Eduardo Coelho Andrade, Jan Damoiseaux, Edward K Chan
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero (14 May, 2019) Free
Hasan Satış, Reyhan Bilici Salman, Aslihan Avanoğlu Güler, Hazan Karadeniz, Şeyma Yıldız, Neslihan Kayahan
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
(4 July, 2019) Free
Johannes Mofors, Sven-Erik Sonesson, Marie Wahren-Herlenius
Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
(16 May, 2019) Free
Zaixing Yang, Yan Liang
Response to: ‘Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh S et al’ by Yang et al
(17 June, 2019) Free
Sara Sabbagh, Iago Pinal Fernandez, Frederick W Miller, Lisa G Rider, Andrew Lee Mammen
Differentiating disease activity from damage in systemic sclerosis: it’s still early days! (22 May, 2019)
Siddharth Jain, Shefali Khanna Sharma
Response to: ‘Differentiating disease activity from damage in systemic sclerosis: it’s still early days!’ by Jain and Sharma (22 May, 2019) Free
Mandana Nikpour
Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al
(22 May, 2019) Free
Frédéric Alain Vandergheynst, Christophe Lelubre
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
(19 June, 2019) Free
Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone (29 May, 2019) Free
Maxime Samson, Bernard Bonnotte
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson and Bonnotte (29 May, 2019) Free
Christoph T Berger, Thomas Daikeler

Main menu

Table of contents

August 2020 - Volume 79 - 8

Editorials

Heroes and pillars of rheumatology

Epidemiology

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Adult Still’s disease

Behcet’s disease

Osteoarthritis

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

August 2020 - Volume 79 - 8

Editorials

Heroes and pillars of rheumatology

Epidemiology

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Systemic lupus erythematosus

Systemic sclerosis

Adult Still’s disease

Behcet’s disease

Osteoarthritis

Letters

Electronic pages

Issue Information